Elixir
Recent News
- Examining Both Sides of the Sirtuin Coin, Genetic Engineering & Biotechnology News, February 22, 2010
- Elixir Fuels Up On Equity, Acquisition Option Deal With Novartis, VentureBeat, May 20, 2009
- Elixir Inks $500M Novartis Option Deal and Closes $12M Financing, BioWorld, May 20, 2009
- Elixir Pharmaceuticals’ Phase III Trial of Metformin-Mitiglinide Combination Therapy , Release, November 18, 2008
- Elixir Pharmaceuticals to Present at the UBS Global Life Sciences Conference , Release, September 18, 2008
- Elixir Pharmaceuticals Announces Exclusive Sirtuin Intellectual Property License Agreement with Boston University , Release, June 30, 2008
- Elixir Pharmaceuticals Announces New Data at the 2008 American Diabetes Association Annual Meeting, Business Wire, June 9, 2008
- Elixir Pharmaceuticals Researchers Publish New Data Validating Ghrelin as a Key Metabolic Regulator, Business Wire, May 27, 2008
- Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science, Business Wire, April 27, 2008
- Elixir Establishes National Diabetes Advisory Board, Business Wire, April 8, 2008
News Archive
- Elixir Completes Enrollment in Pivotal Phase III Clinical Trial for New Diabetes Drug, Business Wire, March 24, 2008
- Elixir Names Presents New Data on Ghrelin Inhibition at Keystone Meeting, Release, February 21, 2008
- Elixir Taps Chief Medical Officer, Boston Business Journal, October 24, 2007
- Elixir Names Paul M. Martha, MD as Chief Medical Officer, Release, October 24, 2007
- Elixir Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering, Genetic Engineering & Biotechnology News, September 23, 2007
